Growing community of inventors

Indianapolis, IN, United States of America

William B Lacefield

Average Co-Inventor Count = 1.51

ph-index = 7

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 179

William B LacefieldRichard L Simon (6 patents)William B LacefieldDavid W Robertson (4 patents)William B LacefieldMarlene L Cohen (4 patents)William B LacefieldWinston S Marshall (2 patents)William B LacefieldDavid T Wong (2 patents)William B LacefieldTerry D Lindstrom (2 patents)William B LacefieldPeter P Ho (2 patents)William B LacefieldWilliam Pfeifer (1 patent)William B LacefieldWilliam B Lacefield (30 patents)Richard L SimonRichard L Simon (30 patents)David W RobertsonDavid W Robertson (42 patents)Marlene L CohenMarlene L Cohen (28 patents)Winston S MarshallWinston S Marshall (37 patents)David T WongDavid T Wong (34 patents)Terry D LindstromTerry D Lindstrom (8 patents)Peter P HoPeter P Ho (7 patents)William PfeiferWilliam Pfeifer (10 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Eli Lilly and Company (30 from 4,447 patents)


30 patents:

1. 5563148 - Specific 5-HT3 antagonists

2. 5442078 - Intermediates for specific 5-HT3 antagonists

3. 5364863 - Specific 5-HT.sub.3 antagonists

4. 4997956 - Certain 2,3-dihydro-2;2-dimethyl-benzothiophene carboxylic acids which

5. 4921982 - 5-halo-2,3-dihydro-2,2-dimethylbenzofuran-7-carboxylic acids useful as

6. 4658061 - 9-aminoalkylfluorenes

7. 4585861 - 1,2,4-triazine derivatives

8. 4552982 - Synthesis of 9-carbamoyl-9-(3-aminopropyl)fluorenes

9. 4513135 - Diaryl-pyrazine derivatives affecting GABA binding

10. 4508735 - Anti-arrhythmic N-alkanoylaminoalkyl fluorenes

11. 4486592 - 9-Carbamoylfluorene derivatives

12. 4452745 - 9-Aminoalkylfluorenes

13. 4382093 - 9-Aminoalkylfluorenes

14. 4318911 - 5,6-Diaryl-1,2,4-triazines as topical antithrombotic agents

15. 4277471 - 1,1-Biphenyl-2-yl alkylamines, formulations and antiarrhythmic treatment

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/30/2025
Loading…